Search - tctmd.com

Displaying 1 - 20 of 53

Sort: Relevancy | Date

News Industry News

Stealth BioTherapeutics Initiates Two Phase 2 Trials Evaluating Elamipretide for the Treatment of Heart Failure

June 27, 2016

News Industry News

BioVentrix Receives CE Marking Certification for Revivent TC™, the First Minimally Invasive Heart Failure Treatment to Restore the Left Ventricle

June 27, 2016

News Industry News

Capricor Therapeutics Reports Positive 12-Month Data from the DYNAMIC Clinical Trial

June 17, 2016

News Industry News

CVRx® Announces that the First Two Patients were Treated in the Phase III Pivotal Trial Evaluating BAROSTIM THERAPY® for the Treatment of Heart Failure

June 06, 2016

News Industry News

Corvia Medical Announces CE Mark Approval and Enrollment of First Patients in Randomized Clinical Study

May 12, 2016

News Industry News

Mast Therapeutics Announces Positive Top-Line Results From Phase 2a Study Of AIR001 In Patients With Heart Failure With Preserved Ejection Fraction (HFpEF) Conducted At Mayo Clinic

January 31, 2016

News Industry News

Study Demonstrates i-cor® Synchronized Cardiac Assist Preserves Left Ventricular (LV) Function Compared to Continuous-Flow ECLS in Cardiogenic Shock

December 15, 2015

News Industry News

BioVentrix Announces 30th Clinical Case Milestone for Revivent-TC™ Technology

December 13, 2015

News Industry News

Mast Therapeutics Initiates Phase 2 Study Of Vepoloxamer For The Treatment Of Chronic Heart Failure

October 26, 2015

News Industry News

Thrombus Aspiration During PCI Shows No Benefit To Standard PCI In Stemi Patients Presenting Late After Symptom Onset

October 13, 2015

News Industry News

Medtronic CoreValve® System Shows Positive Clinical Outcomes in New Patient Populations

October 13, 2015

News Industry News

Extended Follow-Up Of ANTHEM-HF Patients Shows That Benefits Of Autonomic Regulation Therapy Are Maintained After 12 Months

September 28, 2015

News Industry News

Ventrix Initiates Clinical Trial of VentriGel™

September 17, 2015

News Industry News

Biotronik launches China arm in Orsiro stent trial

August 31, 2015

News Industry News

Bayer Expands Finerenone Clinical Development Program with Three Phase III Studies for Finerenone in Patients with Diabetic Kidney Disease and Patients with Chronic Heart Failure

August 31, 2015

News Industry News

Biotronik launches 2 new studies

August 13, 2015

News Industry News

Novartis' new heart failure medicine LCZ696 approved by FDA to reduce risk of cardiovascular death and heart failure hospitalization; now called Entresto™ (sacubitril-valsartan)

July 07, 2015

News Industry News

DC Devices Completes Enrollment In Clinical Trial Of The First Transcatheter Device To Treat Diastolic Heart Failure; Announces Name Change To Corvia Medical

June 22, 2015

News Industry News

Boston Scientific Initiates Global Study To Assess EMBLEM™ Subcutaneous Implantable Defibrillator (S-ICD) In Primary Prevention Patients With Low Ejection Fraction

June 22, 2015

News Industry News

Juventas Therapeutics Granted FDA Fast Track Designation and Phase 2b Protocol Allowance for Novel Heart Failure Gene Therapy

June 16, 2015

Advertisement

Stealth BioTherapeutics Initiates Two Phase 2 Trials Evaluating Elamipretide for the Treatment of Heart Failure

BioVentrix Receives CE Marking Certification for Revivent TC™, the First Minimally Invasive Heart Failure Treatment to Restore the Left Ventricle

Capricor Therapeutics Reports Positive 12-Month Data from the DYNAMIC Clinical Trial

CVRx® Announces that the First Two Patients were Treated in the Phase III Pivotal Trial Evaluating BAROSTIM THERAPY® for the Treatment of Heart Failure

Corvia Medical Announces CE Mark Approval and Enrollment of First Patients in Randomized Clinical Study

Mast Therapeutics Announces Positive Top-Line Results From Phase 2a Study Of AIR001 In Patients With Heart Failure With Preserved Ejection Fraction (HFpEF) Conducted At Mayo Clinic

Study Demonstrates i-cor® Synchronized Cardiac Assist Preserves Left Ventricular (LV) Function Compared to Continuous-Flow ECLS in Cardiogenic Shock

BioVentrix Announces 30th Clinical Case Milestone for Revivent-TC™ Technology

Mast Therapeutics Initiates Phase 2 Study Of Vepoloxamer For The Treatment Of Chronic Heart Failure

Thrombus Aspiration During PCI Shows No Benefit To Standard PCI In Stemi Patients Presenting Late After Symptom Onset

Medtronic CoreValve® System Shows Positive Clinical Outcomes in New Patient Populations

Extended Follow-Up Of ANTHEM-HF Patients Shows That Benefits Of Autonomic Regulation Therapy Are Maintained After 12 Months

Ventrix Initiates Clinical Trial of VentriGel™

Biotronik launches China arm in Orsiro stent trial

Bayer Expands Finerenone Clinical Development Program with Three Phase III Studies for Finerenone in Patients with Diabetic Kidney Disease and Patients with Chronic Heart Failure

Biotronik launches 2 new studies

Novartis' new heart failure medicine LCZ696 approved by FDA to reduce risk of cardiovascular death and heart failure hospitalization; now called Entresto™ (sacubitril-valsartan)

DC Devices Completes Enrollment In Clinical Trial Of The First Transcatheter Device To Treat Diastolic Heart Failure; Announces Name Change To Corvia Medical

Boston Scientific Initiates Global Study To Assess EMBLEM™ Subcutaneous Implantable Defibrillator (S-ICD) In Primary Prevention Patients With Low Ejection Fraction

Juventas Therapeutics Granted FDA Fast Track Designation and Phase 2b Protocol Allowance for Novel Heart Failure Gene Therapy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content